Latest Myopia News

HOYA to Host ‘Managing Myopia’ Panel at WSPOS Virtual Congress

September 16, 2021

BANGKOK — HOYA Vision Care announced that it will be participating in the upcoming World Society of Paediatric Ophthalmology and Strabismus (WSPOS) “Connect 2 The World” Virtual Congress, September 25-26, by hosting a panel discussion on myopia management.

Dr. Hakan Kaymak

The annual Congress, established in 2008, brings experts in pediatric ophthalmology together to focus on important issues and share the latest developments in the field. 

Natalia Vlasak, MD, ophthalmologist and Global Medical and Scientific Affairs Manager at HOYA Vision Care, will be joined by renowned experts Hakan Kaymak, MD, Retina and Myopia Specialist at the University of  Hamburg Private Clinic Düsseldorf, and Weizhong Lan, MD, PhD, professor and vice director of the Aier Institute of Optometry and Vision Science, Aier EYE Hospital Group in China, in a panel discussion entitled “Managing Myopia, Together,” on September 26 at 6:00 am GMT.  

Dr. Weizhong Lan

Dr. Kaymak and Dr. Lan will share their experience in managing myopia, including a live panel discussion focusing on the latest protocols for myopia management. The discussion will include their experience prescribing the HOYA MiYOSMART lens to treat myopia. The session will also discuss the findings of a three-year clinical study recently published in the British Journal of Ophthalmology featuring the results of HOYA’s MiYOSMART spectacle lens. This study, conducted by the Centre for Myopia Research at the Hong Kong Polytechnic University, is a continuation of a two-year study that demonstrated evidence of the lenses’ effectiveness in slowing down the progression of myopia in children ages 8-13.1 

“The MiYOSMART lens has been proven to slow down myopia progression in children ages 8-13,  easily and effectively,” said Dr. Vlasak. “I’m very pleased to have the opportunity to share our latest MiYOSMART clinical research data and to hear from top ophthalmology professionals who will discuss the latest trends in myopia management and share their experience in prescribing this life-enhancing lens product during the WSPOS 2021 Virtual Congress.”  

To see the full schedule for the Virtual Congress, including other myopia-related sessions, click here.


1 Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29  May 2019. doi: 10.1136/bjophthalmol-2018-313739

To Top